Decitabine With Ruxolitinib, Fedratinib or Pacritinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms

Abroad (travel likely)RecruitingPHASE2

Conditions

Acute Myeloid Leukemia · Essential Thrombocythemia · Myelodysplastic Syndrome · Myelodysplastic/Myeloproliferative Neoplasm · Myeloproliferative Neoplasm · Myeloproliferative Neoplasm, Not Otherwise Specified · Polycythemia Vera · Primary Myelofibrosis · Secondary Myelofibrosis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

    Contact: Study coordinator (Noah Pinke) · ntpinke@fredhutch.org · 206-606-4942
    Contact: Principal Investigator (Anna Halpern)
Study leads
  • Anna Halpern

    Principal Investigator

    Fred Hutch/University of Washington Cancer Consortium